logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 12 of 12 Items
Showing 1 - 12 of 12 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia

Abongomera C, Ritmeijer KKD, Vogt F, Buyze J, Mekonnen Z,  et al.
2017-06-05 • PLOS One
2017-06-05 • PLOS One
BACKGROUND
In Ethiopia, case fatality rates among subgroups of visceral leishmaniasis (VL) patients are high. A clinical prognostic score for death in VL patients could contribute to...
Journal Article
|
Letter

Do patents prevent access to drugs for HIV in developing countries?

Boelaert M, Lynen L, Van Damme W, Colebunders R
2002-02-20 • JAMA
2002-02-20 • JAMA
Journal Article
|
Commentary

The use of Ebola convalescent plasma to treat Ebola Virus Disease in resource constrained settings: a perspective from the field

van Griensven J, De Weiggheleire A, Delamou A, Smith PJ, Edwards T,  et al.
2015-08-10 • Clinical Infectious Diseases
2015-08-10 • Clinical Infectious Diseases
The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola Virus Disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone and Liberia, was ...
Journal Article
|
Short Report

Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient

Moreau M, Spencer C, Gozalbes JG, Colebunders R, Lefevre A,  et al.
2015-01-22 • Eurosurveillance
2015-01-22 • Eurosurveillance
Journal Article
|
Commentary

Overlooking the Importance of Immunoassays - Authors' Reply

Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A,  et al.
2016-09-19 • Lancet Infectious Diseases
2016-09-19 • Lancet Infectious Diseases
Journal Article
|
Review

Essentials of Filoviral Load Quantification

Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A,  et al.
2016-06-10 • Lancet Infectious Diseases
2016-06-10 • Lancet Infectious Diseases
Quantitative measurement of viral load is an important parameter in the management of filovirus disease outbreaks because viral load correlates with severity of disease, survival, and in...
Journal Article
|
Research

Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment

Colebunders R, Tshomba A, Van Kerkhove MD, Bausch DG, Campbell P,  et al.
2007-11-15 • Journal of Infectious Diseases
2007-11-15 • Journal of Infectious Diseases
The objective of the present study was to describe day of onset and duration of symptoms of Marburg hemorrhagic fever (MHF), to summarize the treatments applied, and to assess the qualit...
Journal Article
|
Research

No evidence known viruses play a role in the pathogenesis of onchocerciasis-associated epilepsy. An explorative metagenomic case-control study

Roach M, Cantu A, Vieri MK, Cotten M, Kellam P,  et al.
2021-06-22 • Pathogens and Global Health
2021-06-22 • Pathogens and Global Health
Despite the increasing epidemiological evidence that the Onchocerca volvulus parasite is strongly associated with epilepsy in children, hence the name onchocerciasis-associated epilepsy ...
Journal Article
|
Research

Organisation of Health Care During an Outbreak of Marburg Haemorrhagic Fever in the Democratic Republic of Congo, 1999

Colebunders R
2004-05-01 • Journal of Infection
2004-05-01 • Journal of Infection
Organising health care was one of the tasks of the International Scientific and Technical Committee during the 1998-1999 outbreak in Durba/Watsa, in the north-eastern province (Province ...
Journal Article
|
Research

Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008

Roddy P, Howard N, Van Kerkhove MD, Lutwama J, Wamala JF,  et al.
2012-12-28 • PLOS One
2012-12-28 • PLOS One
A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putat...
Journal Article
|
Review

Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options

Roddy P, Colebunders R, Jeffs B, Palma PP, Van Herp M,  et al.
2011-11-01 • Journal of Infectious Diseases
2011-11-01 • Journal of Infectious Diseases
Testing an innovative therapy for filovirus hemorrhagic fever (FHF) in an outbreak setting may be years away. Moreover, beyond anecdotal evidence, little is known about best practice for...
Journal Article
|
Research

The risk and predictors of visceral leishmaniasis relapse in HIV co-infected patients in Ethiopia: a retrospective cohort study

Abongomera C, Diro EGJ, Vogt F, Tsoumanis A, Mekonnen Z,  et al.
2017-10-30 • Clinical Infectious Diseases
2017-10-30 • Clinical Infectious Diseases
BACKGROUND
East Africa, where Leishmania donovani is prevalent, faces the highest burden world-wide of visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) coinfection...